# China NMPA Drug Inspection - Hongxing Pharmaceutical Factory, Guangdong Hongxing Group Co., Ltd. - Baohe Oral Liquid

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/hongxing-pharmaceutical-factory-guangdong-hongxing-group-co-ltd/891a14fb-f99d-4aa4-afff-0e3df1837ce8/
Source feed: China

> China NMPA drug inspection for Hongxing Pharmaceutical Factory, Guangdong Hongxing Group Co., Ltd. published June 17, 2021. Drug: Baohe Oral Liquid. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Guangdong Provincial Drug Administration's Announcement Regarding Drug Sampling and Inspection Information (Issue 4, 2021)
- Company Name: Hongxing Pharmaceutical Factory, Guangdong Hongxing Group Co., Ltd.
- Publication Date: 2021-06-17
- Drug Name: Baohe Oral Liquid
- Inspection Finding: Meets the requirements of drug standards (qualified)
- Action Taken: It does not involve the investigation and handling of substandard drugs.

Company: https://www.globalkeysolutions.net/companies/hongxing-pharmaceutical-factory-guangdong-hongxing-group-co-ltd/a20a9c54-8f79-465f-8fdc-edc462f4c152/